HeartStart OnSite Defibrillator (Model M5066A) and HeartStart Home Defibrillator (Model M5068A)
Philips Medical Systems, Inc. · Decision date Feb 2, 2026
What did the FDA decide?
FDA records P160029/S029 as a supplement to PMA P160029, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 2, 2026.
FDA approval order statement
an update from the current manual manufacturing method to a semi-automated manufacturing method
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 2, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P160029/S029
- Regulatory pathway
- PMA supplement
- Applicant
- Philips Medical Systems, Inc.
- Product code
- NSA
- Decision code
- OK30
- Decision date
- Feb 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Over-the-counter automated external defibrillator.
- Applicant
- Philips Medical Systems, Inc.
- Product code
- NSA
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P160029/S029 received
Application receipt date recorded by FDA.
P160029/S029 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P160029. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Philips Medical Systems, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 22100 Bothell-Everett Hwy., Bothell, WA, 98021
Sources and methodology
- Original FDA record: P160029/S029
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records